Have a feature idea you'd love to see implemented?
Let us know!
NUVB Nuvation Bio Inc
Price (delayed)
$2.7
Market cap
$908.73M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.18
Enterprise value
$889.89M
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and
Highlights
Nuvation Bio's revenue has soared by 51% from the previous quarter
Nuvation Bio's debt has surged by 151% YoY but it has decreased by 24% QoQ
NUVB's equity has surged by 95% since the previous quarter but it is down by 18% year-on-year
The company's quick ratio has shrunk by 76% YoY and by 18% QoQ
The net income has declined by 4.2% since the previous quarter
Key stats
What are the main financial stats of NUVB
Market
Valuations
Earnings
Shares outstanding
336.57M
Market cap
$908.73M
Enterprise value
$889.89M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.34
Price to sales (P/S)
341.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
411.6
Revenue
$2.16M
EBIT
-$532.03M
EBITDA
-$531.65M
Free cash flow
-$99.31M
Per share
Balance sheet
Liquidity
EPS
-$2.18
Free cash flow per share
-$0.36
Book value per share
$2.02
Revenue per share
$0.01
TBVPS
$2.08
Total assets
$571.58M
Total liabilities
$68.87M
Debt
$11.19M
Equity
$502.71M
Working capital
$505.95M
Debt to equity
0.02
Current ratio
9.57
Quick ratio
9.3
Net debt/EBITDA
0.04
Margins
Efficiency
Dividend
EBITDA margin
-24,590.6%
Gross margin
-32.4%
Net margin
-24,619.8%
Operating margin
-25,879.6%
Return on assets
-88.7%
Return on equity
-108.7%
Return on invested capital
-99.1%
Return on capital employed
-103.8%
Return on sales
-24,608.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NUVB stock price
How has the Nuvation Bio stock price performed over time
Intraday
4.65%
1 week
-5.92%
1 month
14.41%
1 year
117.74%
YTD
78.81%
QTD
17.9%
Financial performance
How have Nuvation Bio's revenue and profit performed over time
Revenue
$2.16M
Gross profit
-$700,000
Operating income
-$559.52M
Net income
-$532.28M
Gross margin
-32.4%
Net margin
-24,619.8%
Nuvation Bio's revenue has soared by 51% from the previous quarter
Nuvation Bio's net margin has increased by 31% QoQ
The operating margin rose by 31% QoQ
The operating income has declined by 4% since the previous quarter
Growth
What is Nuvation Bio's growth rate over time
Valuation
What is Nuvation Bio stock price valuation
P/E
N/A
P/B
1.34
P/S
341.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
411.6
NUVB's EPS is down by 2.8% QoQ
NUVB's equity has surged by 95% since the previous quarter but it is down by 18% year-on-year
The stock's price to book (P/B) is 65% less than its 5-year quarterly average of 3.8 and 11% less than its last 4 quarters average of 1.5
Nuvation Bio's revenue has soared by 51% from the previous quarter
Efficiency
How efficient is Nuvation Bio business performance
NUVB's ROS is up by 31% QoQ
NUVB's ROE is down by 10% from the previous quarter
The return on invested capital has declined by 9% since the previous quarter
NUVB's return on assets is down by 7% since the previous quarter
Dividends
What is NUVB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NUVB.
Financial health
How did Nuvation Bio financials performed over time
The company's quick ratio has shrunk by 76% YoY and by 18% QoQ
The current ratio has shrunk by 75% YoY and by 17% QoQ
Nuvation Bio's debt is 98% lower than its equity
Nuvation Bio's debt has surged by 151% YoY but it has decreased by 24% QoQ
The debt to equity has soared by 100% YoY but it has shrunk by 67% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.